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 Abstract 
 Objective:  While there is a dose-response relationship between physical activity (PA) and 
health benefit, little is known about the effectiveness of different PA prescriptions on total 
daily PA.  Aim:  To test, under real-life conditions and using an objective, non-invasive mea-
surement technique (accelerometry), the effect of prescribing additional physical activity 
(walking only) of different durations (30, 60 and 90 min/day) on compliance (to the activity 
prescribed) and compensation (to total daily PA). Participants in each group were prescribed 
5 sessions of walking per week over 4 weeks.  Methods:  55 normal-weight and overweight 
women (mean BMI 25 ± 5 kg/m 2 , height 165 ± 1 cm, weight 68 ± 2 kg and mean age 27 ± 1 
years) were randomly assigned to 3 prescription groups: 30, 60 or 90 min/day PA.  Results: 
 Walking duration resulted in an almost linear increase in the number of steps per day during 
the prescription period from an average of about 10,000 steps per day for the 30-min pre-
scription to about 14,000 for the 90-min prescription. Compliance was excellent for the 30-
min prescription but decreased significantly with 60-min and 90-min prescriptions. In parallel, 
degree of compensation subsequent to exercise increased progressively as length of prescrip-
tion increased. Conclusion:  A 30-min prescription of extra walking 5 times per week was well 
tolerated. However, in order to increase total PA further, much more than 60 min of walking 
may need to be prescribed in the majority of individuals. While total exercise ‘volume’ in-
creased with prescriptions longer than 30 min, compliance to the prescription decreased and 
greater compensation was evident.  © 2014 S. Karger GmbH, Freiburg 
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 Introduction 
 The benefits of physical activity for health are widely acknowledged, with research 
evidence consolidated in a number of landmark reports  [1–3] . To address decreases in 
physical activity at the population level, physical activity guidelines were developed for adults 
 [4] and later updated based on new research evidence  [5] . Despite some variations, physical 
activity guidelines have consistently referenced ‘putting together at least 30-min of moderate-
intensity physical activity on most, preferably all, days of the week’  [5]  to confer health 
benefits. However, this recommended prescription may not be sufficient to compensate for 
the typical reductions in habitual physical activity and predominance of sedentary lifestyle 
behaviours characteristic of many adults. Further, many people regard 30 min of activity as 
a target rather than a minimum  [6] . The degree of compliance to a prescription of 30 min 
physical activity (or multiples of 30 min) per day, and compensation to different physical 
activity prescriptions have not been thoroughly investigated. Both poor compliance and 
compensatory effects associated with engagement in physical activity are key factors likely 
to decrease the effectiveness of physical activity prescriptions. 
 Brisk walking at an individual’s preferred pace is the most commonly reported  [7] and 
recommended physical activity as it meets the minimum intensity to achieve a cardiorespi-
ratory benefit and decrease adiposity in the unfit  [8–10] . Walking is a natural, accessible and 
safe physical activity and does not require special skill or equipment  [6, 11] . However, an 
ongoing challenge relates to the specifics of the activity prescription  [12, 13] . To use self-
paced walking as an example, common questions relate to the duration (how long), frequency 
(how often) and intensity (how hard) of the walking prescription.
 In addition, we ignore how individuals respond to prescriptions of different duration (for 
example, 30 vs. 60 vs. 90 min/day). Depending on the desired health outcome, promotion of 
physical activity has typically referenced benefits associated with increasing physical activity 
in blocks of time ranging from 10 min to more than 1 h  [1, 4, 5, 12] . However, little is known 
about the effectiveness of different prescriptions on the increase in total daily physical activity 
 [5] .
 For example, some research has indicated that at least 60 min/day of moderate-intensity 
physical activity is necessary to prevent weight gain and maximize health benefits  [2] . Other 
reports have claimed that 60–90 min/day of brisk walking is necessary to achieve either long-
term weight loss or the maintenance of body weight  [14, 15] . In addition, the effectiveness of 
physical activity prescriptions is likely to be compromised by both poor compliance and 
compensatory effects. 
 We investigated the response to three walking prescriptions (30, 60 and 90 min/day) in 
a group of normal-weight and overweight women. We measured physical activity using accel-
erometry, calculated intensity scores and estimated physical activity levels and subsequently 
converted data to physical activity energy expenditure (AEE). Further, we calculated both 
compliance and compensation to each prescription.
 Material and Methods 
 Subjects  
 55 normal-weight and overweight women were recruited to the study (mean BMI 25 ± 5 kg/m 2 , height 
165 ± 1 cm, weight 68 ± 2 kg and average age 27 ± 1 years). Women were randomly assigned to 3 walking 
prescription groups: 30, 60 or 90min/day. Selection criteria included: healthy (taking no medication), female, 
aged 18–40 years, non-smokers, no orthopaedic problems limiting mobility, non-obese (BMI < 30 kg/m 2 ). As 
a substantial fraction of the Swiss population (ca. 90%), are normal-weight or overweight, we recruited both 
categories of women.
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 Objectives 
 Given the controversy regarding the specifics of physical activity participation required for health and 
weight maintenance, the purpose of the proposed study was to test, under real-life conditions and using an 
objective, non-invasive measurement (accelerometry), the effect of prescribing additional physical activity 
(walking only) of different duration (30, 60 and 90 min/day) on compliance (to the activity prescribed) and 
compensation (to total daily physical activity). Our interest was to study both normal-weight and overweight 
women as this population are susceptible to weight gain and therefore are a primary target for physical 
activity programmes and interventions.
 Experimental Design  
 A 2-week baseline was used to record habitual physical activity (baseline ‘before’). During week 3–6, 
the physical activity prescription consisted of daily walking (either 30 or 60 or 90 min duration) at the 
preferred walking speed. Participants were asked to add the assigned walking duration to their normal daily 
activity 5 times per week across the 4-week intervention. Two sub-periods (weeks 3 and 4, plus weeks 5 and 
6) were also compared ( fig. 1 ). Although a cross-over design would have been ideal, it was not practical for 
all participants to complete each of the 3 walking prescriptions. Participants were also advised that it was 
acceptable to split the walking duration into blocks of 30 min (i.e., 60 min or 2 × 30 min, 90 min or 3 × 30 min 
etc.). No activity prescription was imposed during the final 2-week block (week 7 and 8) during which partic-
ipants spontaneously returned to their habitual activity (baseline ‘after’). There was a standardized way of 
indicating to the subjects that the prescribed walking physical activity was abandoned and that she was free 
to adopt the strategy she desired. 
 Research Questions 
 Five questions were raised:
 i) What is the compliance to daily walking prescriptions of 30 min vs. 60-min vs. 90 min?
 ii) Does compliance decrease as the duration of prescription increases (i.e., are women less compliant to a 
90-min vs. 60-min vs. 30-min prescription)?
 iii) Is there a compensation effect to the walking prescription with a concomitant spontaneous decrease in 
physical activities of daily living?
 iv) Is the putative compensatory effect greater with increased duration of walking prescription?
 v) What is the net effect (true effect) of each of the walking prescriptions on daily AEE?
 Fig. 1. Experimental design. Note the double baseline periods before and after intervention (2 weeks each), 
allowing first a comparison of activity between the 2 baseline periods and second the ability to track any 
continuation of walking (carry over) beyond the completion of the 4-week physical activity prescription. 
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 Data Acquisition and Analysis  
 Physical activity level was inconspicuously monitored using a miniaturized uniaxial accelerometer 
weighing less than 30 g (Lifecorder ;  Suzuken Co. Ltd., Nagoya, Japan). Physical activity was then categorized 
into 11 levels (0, 0.5 and 1–9; level 0 corresponding to <0.06 gravity unit) based on the pattern of the accel-
eration signal. Activity levels were subsequently converted by a proprietary algorithm to obtain AEE. Resting 
metabolic rate was calculated taking into account anthropometric data of participants (body weight, height, 
gender and age). In addition, the number of steps/day was measured by the accelerometer with great 
accuracy. The device has been extensively tested and validated in our laboratory using a whole-body calo-
rimeter  [16, 17] .
 Calculation of Indices 
 Compliance during the prescription period was defined as the ratio of continuous walking duration 
(measured by accelerometry) to prescribed walking duration:
 Compliance index (%)  = effective walking duration (min) / prescribed walking duration (min) × 100.
 Compensation was defined as the ratio between the expected and the observed increase in steps per 
day (measured by accelerometry) resulting from the walking prescription. 
 Net walking activity duration was the difference in measured continuous walking between baseline and 
prescription period: 
 Compensation index (%) = observed rise in steps/day due to prescription / expected increase in steps/
day due to effective exercise duration × 100. 
 Statistical Methods 
 Between-treatment comparisons (30 vs. 60 vs. 90 min) were analysed by ANOVA. In order to track 
which of the treatments was different from another, a multiple comparison t-test was performed with 
Bonferroni corrections. 
 Results 
 Steps per Day 
 As anticipated, an increase in walking duration resulted in an almost linear increase 
in the number of steps/day during the prescription period ( fig. 2 ). The baseline numbers 
of steps/day (before and after the prescription) were not significantly different between 
the 3 groups. Mean steps/day varied from about 7,500 to 9,000. These data indicate that 
activity levels of participants were similar to those of earlier studies in Swiss women  [18] 
but somewhat higher than in a recent study  [19] . From baseline to the first prescription 
period there was a significant increase in steps for both 60- and 90-min groups (from 
about 8,000 to 11,000 and from about 9,000 to 13,000, respectively). A similar pattern was 
evidenced during the second prescription period. In each case, total steps/day were signif-
icantly greater in the 90-min than in the 30-min groups (p < 0.01). Further, total steps in 
the 90-min group were significantly different to the post-prescription activity level (p < 
0.01).
 Walking Duration 
 There was a net increase in walking duration (min/day) across each prescription group 
for both 2-week prescription blocks ( fig. 3 ). Mean walk time in each 2-week block was signif-
icantly greater in the 90-min group (70 and 65 min), than in the 60-min group (47.5 and 40 
min) and 30-min group (33 and 30 min).
 Compliance to Exercise 
 Compliance to walking prescription (the ability to complete the daily walking prescription) 
was high during each 2-week period (110 and 100%) for the 30-min group but reduced 
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 Fig. 2. Total number of steps over 24 h during the baseline, prescription periods (first and second) and post-
prescription periods. Values are shown as mean ± SEM.  * * p < 0.001 versus baseline and post prescription.  * p 
< 0.01 versus baseline.  # p < 0.05 versus 30-min prescription. 
 Fig. 3. Net increase in walking duration (over baseline) during the first and second walking prescription pe-
riod (2 weeks each). Dotted lines represent the 3 durations prescribed. Values are shown as mean ± SEM.  
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 Fig. 4. Relative compliance (adherence) to walking prescription during each walking prescription period. 
Values are shown as mean ± SEM.  
 Fig. 5. Relative compensation (%) to walking prescription. Values are shown as mean ± SEM.  # p < 0.05 versus 
30-min prescription. 
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substantially with longer prescriptions to 75 and 60% for the 60-min and 80 and 70% for the 
90-min group. In short, compliance was excellent for the 30-min walking prescription but 
decreased significantly for the 60-min and 90-min prescriptions ( fig. 4 ).
 Compensatory Effect to Activity Prescription 
 Similar to compliance, compensation (%) increased progressively as length of prescription 
increased. The average compensation rate (based on change in steps/day and exercise 
duration), was 25 ± 16% with substantial inter-individual variation. Compensation ranged 
from less than 10% for 30-min walking prescription – i.e. extra activity prescription did not 
significantly reduce the baseline activity level – to 65% for 90-min prescription (p < 0.05) – 
i.e. two thirds of the additional prescription was offset by a blunting of physical activity in the 
post-intervention period ( fig. 5 ).
 Activity Energy Expenditure  
 Finally, as shown in  fig. 6 , activity energy expenditure (AEE) increased significantly with 
an increase in duration of walking prescription (p < 0.01 vs. baseline and p< 0.05 vs. 30-min 
prescription). The expected effect on AEE was higher than the real effect as compliance to the 
prescribed exercise was never 100%, as identified above. 
 On average, the walking prescription increased total energy expenditure by 3% (30-min 
prescription), by 6% (60-min prescription) and by 9% (90-min prescription). 
 Discussion 
 Based on the very low proportion of adults who meet physical activity guidelines when 
assessed using objective measures  [20, 21] , the promotion of physical activity, particularly 
walking, is a public health priority  [6, 22] . Earlier research has demonstrated the health 
benefits of both accumulated and continuous bouts of physical activity  [1, 4] . However, very 
few studies have assessed the relationship between physical activity prescriptions of different 
durations and compliance and compensation. As far as we are aware, this is the first study to 
 Fig. 6. AEE. Values are shown as mean ± SEM.  * * p < 0.001 versus baseline and post-prescription.  * p < 0.01 
versus baseline.  # p < 0.05 versus 30-min prescription. 
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evaluate differences between walking prescription of various durations in healthy, normal-
weight and overweight European women.
 The current analyses provide some key pointers in relation to the public health promotion 
of physical activity. From a practical perspective, the commonly employed prescription of 30 
min/day of self-paced walking, in addition to habitual physical activity, was well tolerated in 
our sample of women. Due to good compliance and limited compensation, the 30-min 
prescription resulted in participants increasing their daily continuous walking by about 30 
min.
 In contrast, and as a function of reduced compliance and increased compensation, the 
longer prescriptions (60 and 90 min) were not achieved by most participants. Abel et al.  [23] 
recently reported that an objective and practical guide to individuals meeting the moderate-
intensity activity level necessary to achieve the current recommendation is to use a pedometer/
accelerometer to count 100 steps/min. Such an approach, which assumes a reasonably 
constant gait cycle (step rate and step length, hence speed), may also be valuable as the length 
of walking prescription increases.
 The rationale for promoting walking as the preferred mode of activity to meet physical 
activity recommendations is based on the simplicity of the activity, its relative safety and its 
effectiveness in promoting health. An additional underlying principle is that moderate-
intensity activity was enjoyable for adults across a wide age and fitness range. Whilst not the 
focus of the current study, Ekkikakis et al.  [24] have postulated that greater attention should 
be paid to the causal chain linking intensity of physical activity to affect and adherence. For 
some individuals, the impost of longer prescriptions in the current study may have influenced 
the enjoyment of walking and both compliance and compensation. Practical constraints 
certainly exist of finding an extra time window in their daily routine. 
 In a recent randomized controlled trial in adult men and women, Samuels et al.  [19] 
examined differences between groups prescribed i) 10,000 steps/day ii) 30-min/day of 
continuous moderate-intensity physical activity or iii) 30 min/day of moderate-intensity 
physical activity accumulated in bouts of at least 10 min. Physical activity was assessed by 
pedometers/accelerometers, and self-efficacy was measured over the 5-week intervention. 
The authors found that, as compared to the other approaches, the 10,000 step/day guideline 
resulted in the greatest increase in physical activity above baseline values.
 While walking at a moderate-intensity, the expectation is that most individuals would 
accumulate 3–4,000 steps in a 30-min walk at 100–130 steps/min. This was confirmed in the 
current study, with the daily step count for participants in the 30-min prescription group 
being almost 10,000 during the intervention period ( fig. 2 ). The 30-min group in the study by 
Samuels et al.  [19] was of particular interest since, on days they met the physical activity 
recommendation, the subjects increased daily steps by 3,500 above baseline and reached 
about 10,000 steps/day. Our study confirms this observation.
 Practical Recommendations 
 A walking prescription of 90 min/day may be an unrealistic recommendation for many 
working women as we found evidence of a degradation in compliance to the prescription with 
a correspondingly large compensation. However, the net walking duration completed by 
those prescribed 60 or 90 min/day was higher than in those subjects with 30-min prescription. 
An alternative option to obviate this poor compliance may be to encourage, where possible, 
an increase in the intensity of exercise by performing more vigorous activities such as very 
brisk walking. Such advice parallels the more recent physical activity recommendations 
which encompass both moderate- and vigorous-intensity activities  [5] .
 In summary, a 30-min prescription of extra walking was well tolerated across the 4-week 
intervention with participants consistently achieving the prescription. To significantly 
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increase total physical activity beyond 30 min/day, much more than 60 min of walking should 
be prescribed to account for both high compensation and low compliance to the extra exercise. 
Due to time constraints, prescriptions of 60 min/day of physical activity or longer may be 
difficult to follow for an extended period in some individuals, since it involves a reorgani-
zation of daily leisure activities. Williams  [25] recently reported that distance walked provides 
a better assessment of the volume of activity undertaken than time spent walking. Potentially, 
greater compliance to longer prescriptions (>30 min/day) may be achieved using a distance 
as opposed to target time, particularly recognising the common overestimation of self-
reported physical activity. In practical terms, this means that the distance should be tracked 
rather than the time: today a simple smartphone with an appropriate application using accel-
erometry/GPS is capable of doing this with reasonable accuracy.
 Limitations 
 We acknowledge a number of limitations related to the current study. Participants were 
healthy volunteers who were reasonably active compared to physically inactive participants 
in other studies  [19] . It would also have been preferable to employ a cross-over design but, 
as noted, this was not possible in the present study. Future research should also examine the 
impact of different activity prescriptions on compliance over a longer time period than 1 
month. Further, as this work was only undertaken in women, it is unclear whether there are 
gender differences in responsiveness to different prescriptions. In addition, similar work 
should be undertaken in obese adults to better understand the impact of activity prescription 
across the normal-weight to obesity continuum. These limitations notwithstanding, we 
believe that the results of the present study provide important information regarding the 
impact of walking prescriptions of different duration in normal-weight and overweight 
European women. 
 Conclusion 
 The classical minimal recommendation of 30 min/day walking prescription was found to 
be realistic and assured excellent adherence in both non-obese and overweight individuals.
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